Hepatitis latest research

In response to the World Health Organization's current focus on treating hepatitis and reducing infections worldwide, Dove Medical Press has compiled the latest research on hepatitis and hepatocellular carcinoma across our portfolio of journals. Thank you to our community of authors and peer reviewers who continue to contribute to the campaign against this disease.

This content is free to access and updated daily.

- 581 records -

Stage-Dependent Efficacy of TACE Combined with Tyrosine Kinase and Immune Checkpoint Inhibitors as Conversion Therapy for Unresectable Hepatocellular Carcinoma: A Multicenter Retrospective Study

Zhou H, Ye L, Yue W, Lin K, Chi B, Liao J, Chen X, Shi H, Wang T, Jiang Z, Luo J, Huang B, Yu Y, He Q

Journal of Hepatocellular Carcinoma 2026, 13:619735

Published Date: 17 July 2026

Pretreatment Prognostic Nutritional Index Predicts Progression-Free Survival in BCLC Stage C Hepatocellular Carcinoma Treated with Sorafenib

Youtube play button
Youtube thumbnail

Aydın U, Dikilitaş M, Balıkçı Çiçek İ, Pamuk ÖA, Sadak Öcal Z, Danacı Y, Alizade E

Cancer Management and Research 2026, 18:621105

Published Date: 14 July 2026

SNHG6 Promotes Lipid Metabolic Reprogramming in Hepatocellular Carcinoma via Upregulation of SCD

Zheng X, Lu J, Qiu H, Jin Q, Cao L, Liu J, Song P, Yao S

Journal of Hepatocellular Carcinoma 2026, 13:610313

Published Date: 10 July 2026

Tumor Burden Thresholds Associated with Successful Downstaging After Yttrium-90 Radioembolization in Hepatocellular Carcinoma Beyond UCSF Criteria

Chiu CH, Yu CY, Ou HY, Tsang LC, Huang PH, Weng CC, Lu Y, Chen CL, Cheng YF

Journal of Hepatocellular Carcinoma 2026, 13:613375

Published Date: 10 July 2026

Efficacy and Safety of Modified Sishen Decoction for Tyrosine Kinase Inhibitor-Induced Diarrhea in Hepatocellular Carcinoma: A Randomized Controlled Trial

Cao J, He S, Yu S, Shen J, Hu N, Yu D, Cao T, Jiang L, Peng J, Zhai X

Journal of Hepatocellular Carcinoma 2026, 13:608479

Published Date: 9 July 2026

SPP1+ Macrophages Promote Immunosuppression in Post-TACE Hepatocellular Carcinoma Involving Lactate-Induced Lactylation and Potential SPP1-CD44 Signaling

Wang H, Liang G, Liu T, He M, Jiang Y, Li J, Ouyang Y, Hao S, Liu W, Li J

Journal of Hepatocellular Carcinoma 2026, 13:603485

Published Date: 8 July 2026

Clinical Value of Inflammatory Indexes in Predicting Post-Transplantation Prognosis in Hepatocellular Carcinoma: A Retrospective Cohort Study

Wang HX, Ye XY, Jiang T, Lyu SC, He Q, Ji ZL, Lang R

Journal of Inflammation Research 2026, 19:610101

Published Date: 3 July 2026

Preoperative Prediction of Glypican-3 Expression in Hepatocellular Carcinoma Using Sonazoid Contrast-Enhanced Ultrasound Radiomics

Yang S, Huang Z, Zheng W, Li L, Xue Y, Zou R, Peng C

Journal of Hepatocellular Carcinoma 2026, 13:610969

Published Date: 30 June 2026

A Nomogram to Predict Day-7 Total Bilirubin in Hepatitis B Virus-Related Cirrhosis: An Early Treatment-Response Assessment Tool

Yang Y, He C, Yang Y, Zhao Y, Dong X, Liang D

Infection and Drug Resistance 2026, 19:611768

Published Date: 30 June 2026

Angiogenic Prognostic Signature for Stratification in Hepatocellular Carcinoma

Zhu Z, Guo C, Shen H, Zeng S, Li N

Journal of Hepatocellular Carcinoma 2026, 13:600117

Published Date: 20 June 2026

Machine Learning-Based Radiopatho-Clinical Model Integrating Ultrasound Radiomics and Kleiner Score for Prognosis Prediction in NAFLD-Related Hepatocellular Carcinoma

Li CL, Jia Z, Yao ZY, Cui XT, Sun A, Hao AY, Chen ZY, Chen F, Cao JY, Wang ZS

Journal of Hepatocellular Carcinoma 2026, 13:611041

Published Date: 19 June 2026

Hepatocellular Carcinoma Precursor Lesions: From Pathological Basis to Risk Stratification and Precision Intervention

Yan R, Zhang H, Jiao J, Huang Q, Wang N, Bao J, Li X, Yan S, Li J

Journal of Hepatocellular Carcinoma 2026, 13:613101

Published Date: 18 June 2026

TACE Combined with Ralox-HAIC (Oxaliplatin Puls Raltitrexed) and System Therapy in Patients with Unresectable Hepatocellular Carcinoma

Liu R, Cao G, Li L, Liu J, Cao H, Xing M, Feng Y, Li Z, Wang B

Journal of Hepatocellular Carcinoma 2026, 13:609273

Published Date: 18 June 2026

Development and Validation of a Machine Learning-Based Individualized Model to Predict TKI Benefit in Postoperative Recurrent HCC

Li M, Jiang Y, Gong L, Sun R, Hao A, Liu K, Luan K, Jia Z, Zhang S, Liu K, Tan B, Hu W, Qu C, Cao J

Journal of Hepatocellular Carcinoma 2026, 13:599142

Published Date: 16 June 2026

Aberrant Cholesterol Metabolism Caused by Decreased Lecithin: Cholesterol Acyltransferase Promoted Hepatocarcinogenesis

Gao H, Peng X, Wen Y, Gou L, Xu Y, Qu X, Wu J, Xue B

Journal of Hepatocellular Carcinoma 2026, 13:562838

Published Date: 15 June 2026

Impact of Microwave Ablation on Growth Kinetics of Residual versus Synchronous Untreated Hepatocellular Carcinoma: A Retrospective Cohort Study

Yi W, Pang C, Xue J, Zhang Y, Chen X, Luo T, Zhang D, Gao X, Yu J, Liang P

Journal of Hepatocellular Carcinoma 2026, 13:603442

Published Date: 4 June 2026

HAIC Combined with Lenvatinib and Pembrolizumab for Unresectable Hepatocellular Carcinoma: A Retrospective Study

Liang J, Yang Z, Yang Z, Li H, Hong J, Pan Y, Fu Y, Wang J, Zhou Z, Zhang Y, Chen M, Chen J, Hu D

Journal of Hepatocellular Carcinoma 2026, 13:600557

Published Date: 26 May 2026

Efficacy and Safety of TACE-HAIC Combined with Molecular Targeted Therapy and Immune Checkpoint Inhibitors for Unresectable Hepatocellular Carcinoma

Feng Z, Wang X, Xu J, Chen S, Hao M, Hu H, Qiu S, Liao Y, Yu W, Fang Z

Journal of Hepatocellular Carcinoma 2026, 13:588860

Published Date: 22 May 2026

A Preoperative MRI-Based Score to Predict High-Risk Pathology and Stratify Adjuvant Therapy Benefit in BCLC 0/A Hepatocellular Carcinoma

Li H, Wang X, Yu C, Li B, Hu Z, Li W, Chen Y, Zhou Y, Sun Y

Journal of Hepatocellular Carcinoma 2026, 13:605420

Published Date: 22 May 2026

More articles